A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The project was undertaking by Qilu Hospital of Shandong University and other well-known
hospitals in China. Aims at evaluating efficacy and safety of rhTPO in management of ITP in
pregnancy.
Phase:
Phase 3
Details
Lead Sponsor:
Shandong University
Collaborators:
Institute of Hematology & Blood Diseases Hospital Qingdao University Southern Medical University, China The Affiliated Hospital of Qingdao University The Second Hospital of Hebei Medical University